"A service of Geisinger Medical Center, Geisinger 's Hazleton Cancer Center specializes in diagnosing and treating cancer and hematologic diseases. The facility offers Chemotherapy IV infusions Injections Hydrations Blood transfusions Bone marrow biopsies On-site lab The clinic also has a dedicated social worker/patient navigator who is available to help patients navigate their cancer care, providing access to various resources and support systems."

During the past decade, Geisinger Medical Center-Cancer Center Hazleton conducted 98 clinical trials. In the 10-year time frame, 98 clinical trials started and 152 clinical trials were completed, i.e. on average, 155.1% percent of trials that started reached the finish line to date. In the past 5 years, 26 clinical trials started and 69 clinical trials were completed. i.e. 265.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Geisinger Medical Center-Cancer Center Hazleton" #1 sponsor was "National Cancer Institute (NCI)" with 104 trials, followed by "Alliance for Clinical Trials in Oncology" with 54 trials sponsored, "SWOG Cancer Research Network" with 27 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 21 trials sponsored and "Eastern Cooperative Oncology Group" with 21 trials sponsored. Other sponsors include 23 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Geisinger Medical Center-Cancer Center Hazleton" #1 collaborator was "National Cancer Institute (NCI)" with 133 trials as a collaborator, "NRG Oncology" with 18 trials as a collaborator, "SWOG Cancer Research Network" with 10 trials as a collaborator, "Cancer and Leukemia Group B" with 9 trials as a collaborator and "NCIC Clinical Trials Group" with 9 trials as a collaborator. Other collaborators include 47 different institutions and companies that were collaborators in the rest 38 trials.

According to Clinical.Site data, the most researched conditions in "Geisinger Medical Center-Cancer Center Hazleton" are "Breast Cancer" (14 trials), "Lymphoma" (9 trials), "Leukemia" (8 trials), "Recurrent Breast Carcinoma" (8 trials) and "Recurrent Squamous Cell Lung Carcinoma" (8 trials). Many other conditions were trialed in "Geisinger Medical Center-Cancer Center Hazleton" in a lesser frequency.

Most popular intervention types in "Geisinger Medical Center-Cancer Center Hazleton" are "Drug" (200 trials), "Other" (154 trials), "Biological" (101 trials), "Procedure" (41 trials) and "Radiation" (14 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (79 trials), "Quality-of-Life Assessment" (53 trials), "Paclitaxel" (28 trials), "Carboplatin" (26 trials) and "Questionnaire Administration" (26 trials). Other intervention names were less common.

The vast majority of trials in "Geisinger Medical Center-Cancer Center Hazleton" are 190 trials for "All" genders, 47 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Geisinger Medical Center-Cancer Center Hazleton". undefined are not yet recruiting, 28 are recruiting, 94 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 95 completed trials in Geisinger Medical Center-Cancer Center Hazleton, 2 suspended trials, and 18 terminated clinical trials to date.

Out of the total trials that were conducted in Geisinger Medical Center-Cancer Center Hazleton, 9 "Phase 1" clinical trials were conducted, 117 "Phase 2" clinical trials and 114 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".